Brenneman DE - Search Results

1

Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity.

Brenneman DE, Hauser JM, Spong C, Phillips TM. Brenneman DE, et al. Neuropeptides. 2002 Aug;36(4):271-80. doi: 10.1016/s0143-4179(02)00045-8. Neuropeptides. 2002. PMID: 12372701

2

Complex array of cytokines released by vasoactive intestinal peptide.

Brenneman DE, Phillips TM, Hauser J, Hill JM, Spong CY, Gozes I. Brenneman DE, et al. Neuropeptides. 2003 Apr;37(2):111-9. doi: 10.1016/s0143-4179(03)00022-2. Neuropeptides. 2003. PMID: 12747943

3

VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death.

Brenneman DE, Hauser J, Spong CY, Phillips TM, Pert CB, Ruff M. Brenneman DE, et al. Brain Res. 1999 Aug 14;838(1-2):27-36. doi: 10.1016/s0006-8993(99)01644-3. Brain Res. 1999. PMID: 10446313

4

Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity.

Brenneman DE, Hauser J, Spong CY, Phillips TM. Brenneman DE, et al. Ann N Y Acad Sci. 2000;921:109-14. doi: 10.1111/j.1749-6632.2000.tb06956.x. Ann N Y Acad Sci. 2000. PMID: 11193813

5

Protective peptides that are orally active and mechanistically nonchiral.

Brenneman DE, Spong CY, Hauser JM, Abebe D, Pinhasov A, Golian T, Gozes I. Brenneman DE, et al. J Pharmacol Exp Ther. 2004 Jun;309(3):1190-7. doi: 10.1124/jpet.103.063891. Epub 2004 Mar 8. J Pharmacol Exp Ther. 2004. PMID: 15007105

6

Vasoactive intestinal peptide releases interleukin-1 from astrocytes.

Brenneman DE, Hill JM, Gozes I, Phillips TM. Brenneman DE, et al. Ann N Y Acad Sci. 1996 Dec 26;805:280-7; discussion 287-9. doi: 10.1111/j.1749-6632.1996.tb17490.x. Ann N Y Acad Sci. 1996. PMID: 8993410 No abstract available.

7

Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide.

Brenneman DE, Phillips TM, Festoff BW, Gozes I. Brenneman DE, et al. Ann N Y Acad Sci. 1997 Apr 24;814:167-73. doi: 10.1111/j.1749-6632.1997.tb46155.x. Ann N Y Acad Sci. 1997. PMID: 9160969 Review.

8

Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.

Brenneman DE, Hauser J, Neale E, Rubinraut S, Fridkin M, Davidson A, Gozes I. Brenneman DE, et al. J Pharmacol Exp Ther. 1998 May;285(2):619-27. J Pharmacol Exp Ther. 1998. PMID: 9580606

9

VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.

Brenneman DE, Glazner G, Hill JM, Hauser J, Davidson A, Gozes I. Brenneman DE, et al. Ann N Y Acad Sci. 1998 Dec 11;865:207-12. doi: 10.1111/j.1749-6632.1998.tb11180.x. Ann N Y Acad Sci. 1998. PMID: 9928014 Review.

10

Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism.

Brenneman DE, Hauser J, Phillips TM, Davidson A, Bassan M, Gozes I. Brenneman DE, et al. Ann N Y Acad Sci. 1999;897:17-26. doi: 10.1111/j.1749-6632.1999.tb07875.x. Ann N Y Acad Sci. 1999. PMID: 10676432 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters